Logo image of AKZA.AS

AKZO NOBEL N.V. (AKZA.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:AKZA - NL0013267909 - Common Stock

58.1 EUR
+0.08 (+0.14%)
Last: 12/19/2025, 7:00:00 PM
Fundamental Rating

4

Overall AKZA gets a fundamental rating of 4 out of 10. We evaluated AKZA against 70 industry peers in the Chemicals industry. There are concerns on the financial health of AKZA while its profitability can be described as average. AKZA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

AKZA had positive earnings in the past year.
In the past year AKZA had a positive cash flow from operations.
Each year in the past 5 years AKZA has been profitable.
Each year in the past 5 years AKZA had a positive operating cash flow.
AKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFAKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

With a Return On Assets value of 0.42%, AKZA perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
AKZA's Return On Equity of 1.48% is in line compared to the rest of the industry. AKZA outperforms 48.57% of its industry peers.
AKZA has a Return On Invested Capital (3.70%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for AKZA is in line with the industry average of 6.86%.
Industry RankSector Rank
ROA 0.42%
ROE 1.48%
ROIC 3.7%
ROA(3y)3.08%
ROA(5y)4%
ROE(3y)10.07%
ROE(5y)11.29%
ROIC(3y)5.38%
ROIC(5y)6.02%
AKZA.AS Yearly ROA, ROE, ROICAKZA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

AKZA has a Profit Margin (0.56%) which is comparable to the rest of the industry.
AKZA's Profit Margin has declined in the last couple of years.
AKZA's Operating Margin of 4.84% is in line compared to the rest of the industry. AKZA outperforms 51.43% of its industry peers.
In the last couple of years the Operating Margin of AKZA has remained more or less at the same level.
With a Gross Margin value of 39.78%, AKZA perfoms like the industry average, outperforming 54.29% of the companies in the same industry.
In the last couple of years the Gross Margin of AKZA has remained more or less at the same level.
Industry RankSector Rank
OM 4.84%
PM (TTM) 0.56%
GM 39.78%
OM growth 3Y-9.79%
OM growth 5Y-1.14%
PM growth 3Y-16.36%
PM growth 5Y-2.73%
GM growth 3Y-0.19%
GM growth 5Y-1.09%
AKZA.AS Yearly Profit, Operating, Gross MarginsAKZA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

AKZA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
AKZA has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for AKZA has been reduced compared to 5 years ago.
Compared to 1 year ago, AKZA has an improved debt to assets ratio.
AKZA.AS Yearly Shares OutstandingAKZA.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AKZA.AS Yearly Total Debt VS Total AssetsAKZA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.05 indicates that AKZA is not a great score, but indicates only limited risk for bankruptcy at the moment.
AKZA has a worse Altman-Z score (2.05) than 60.00% of its industry peers.
AKZA has a debt to FCF ratio of 10.17. This is a negative value and a sign of low solvency as AKZA would need 10.17 years to pay back of all of its debts.
AKZA has a Debt to FCF ratio (10.17) which is in line with its industry peers.
AKZA has a Debt/Equity ratio of 0.93. This is a neutral value indicating AKZA is somewhat dependend on debt financing.
AKZA has a worse Debt to Equity ratio (0.93) than 77.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 10.17
Altman-Z 2.05
ROIC/WACC0.65
WACC5.69%
AKZA.AS Yearly LT Debt VS Equity VS FCFAKZA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

AKZA has a Current Ratio of 1.25. This is a normal value and indicates that AKZA is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.25, AKZA is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
AKZA has a Quick Ratio of 1.25. This is a bad value and indicates that AKZA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of AKZA (0.92) is worse than 61.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.92
AKZA.AS Yearly Current Assets VS Current LiabilitesAKZA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

The earnings per share for AKZA have decreased by -2.93% in the last year.
Measured over the past 5 years, AKZA shows a small growth in Earnings Per Share. The EPS has been growing by 4.44% on average per year.
Looking at the last year, AKZA shows a decrease in Revenue. The Revenue has decreased by -2.03% in the last year.
Measured over the past years, AKZA shows a small growth in Revenue. The Revenue has been growing by 2.92% on average per year.
EPS 1Y (TTM)-2.93%
EPS 3Y-1.33%
EPS 5Y4.44%
EPS Q2Q%-11.4%
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y3.76%
Revenue growth 5Y2.92%
Sales Q2Q%-4.54%

3.2 Future

Based on estimates for the next years, AKZA will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.67% on average per year.
Based on estimates for the next years, AKZA will show a small growth in Revenue. The Revenue will grow by 4.06% on average per year.
EPS Next Y4.39%
EPS Next 2Y8.23%
EPS Next 3Y8.88%
EPS Next 5Y9.67%
Revenue Next Year-3.24%
Revenue Next 2Y-1.87%
Revenue Next 3Y0.61%
Revenue Next 5Y4.06%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AKZA.AS Yearly Revenue VS EstimatesAKZA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
AKZA.AS Yearly EPS VS EstimatesAKZA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.96, which indicates a correct valuation of AKZA.
Based on the Price/Earnings ratio, AKZA is valued a bit cheaper than the industry average as 77.14% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.38. AKZA is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 12.75, AKZA is valued correctly.
Based on the Price/Forward Earnings ratio, AKZA is valued a bit cheaper than 70.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AKZA to the average of the S&P500 Index (23.83), we can say AKZA is valued slightly cheaper.
Industry RankSector Rank
PE 15.96
Fwd PE 12.75
AKZA.AS Price Earnings VS Forward Price EarningsAKZA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

64.29% of the companies in the same industry are cheaper than AKZA, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AKZA indicates a somewhat cheap valuation: AKZA is cheaper than 74.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.89
EV/EBITDA 15.89
AKZA.AS Per share dataAKZA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AKZA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.64
PEG (5Y)3.59
EPS Next 2Y8.23%
EPS Next 3Y8.88%

3

5. Dividend

5.1 Amount

AKZA has a Yearly Dividend Yield of 3.54%.
Compared to an average industry Dividend Yield of 2.49, AKZA pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.87, AKZA pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.54%

5.2 History

The dividend of AKZA decreases each year by -21.52%.
Dividend Growth(5Y)-21.52%
Div Incr Years0
Div Non Decr Years4
AKZA.AS Yearly Dividends per shareAKZA.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

691.38% of the earnings are spent on dividend by AKZA. This is not a sustainable payout ratio.
DP691.38%
EPS Next 2Y8.23%
EPS Next 3Y8.88%
AKZA.AS Yearly Income VS Free CF VS DividendAKZA.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
AKZA.AS Dividend Payout.AKZA.AS Dividend Payout, showing the Payout Ratio.AKZA.AS Dividend Payout.PayoutRetained Earnings

AKZO NOBEL N.V.

AMS:AKZA (12/19/2025, 7:00:00 PM)

58.1

+0.08 (+0.14%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-22 2025-10-22/bmo
Earnings (Next)01-27 2026-01-27/amc
Inst Owners68.31%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap9.94B
Revenue(TTM)10.40B
Net Income(TTM)58.00M
Analysts76.52
Price Target70 (20.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.54%
Yearly Dividend1.98
Dividend Growth(5Y)-21.52%
DP691.38%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.89%
Min EPS beat(2)-7.4%
Max EPS beat(2)-6.38%
EPS beat(4)0
Avg EPS beat(4)-11.39%
Min EPS beat(4)-27.6%
Max EPS beat(4)-4.18%
EPS beat(8)1
Avg EPS beat(8)-8.1%
EPS beat(12)2
Avg EPS beat(12)-11.74%
EPS beat(16)4
Avg EPS beat(16)-11.18%
Revenue beat(2)0
Avg Revenue beat(2)-3.03%
Min Revenue beat(2)-5.13%
Max Revenue beat(2)-0.93%
Revenue beat(4)1
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-5.13%
Max Revenue beat(4)1.79%
Revenue beat(8)1
Avg Revenue beat(8)-1.51%
Revenue beat(12)3
Avg Revenue beat(12)-1.43%
Revenue beat(16)3
Avg Revenue beat(16)-1.57%
PT rev (1m)-1.55%
PT rev (3m)-1.08%
EPS NQ rev (1m)14.62%
EPS NQ rev (3m)4.3%
EPS NY rev (1m)-2.37%
EPS NY rev (3m)-4.71%
Revenue NQ rev (1m)-0.63%
Revenue NQ rev (3m)-0.82%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.8%
Valuation
Industry RankSector Rank
PE 15.96
Fwd PE 12.75
P/S 0.96
P/FCF 18.89
P/OCF 11.71
P/B 2.53
P/tB 68.07
EV/EBITDA 15.89
EPS(TTM)3.64
EY6.27%
EPS(NY)4.56
Fwd EY7.84%
FCF(TTM)3.08
FCFY5.29%
OCF(TTM)4.96
OCFY8.54%
SpS60.83
BVpS22.98
TBVpS0.85
PEG (NY)3.64
PEG (5Y)3.59
Graham Number43.38
Profitability
Industry RankSector Rank
ROA 0.42%
ROE 1.48%
ROCE 5.56%
ROIC 3.7%
ROICexc 4.33%
ROICexgc 8.48%
OM 4.84%
PM (TTM) 0.56%
GM 39.78%
FCFM 5.06%
ROA(3y)3.08%
ROA(5y)4%
ROE(3y)10.07%
ROE(5y)11.29%
ROIC(3y)5.38%
ROIC(5y)6.02%
ROICexc(3y)6.53%
ROICexc(5y)7.21%
ROICexgc(3y)12.06%
ROICexgc(5y)13.03%
ROCE(3y)9.71%
ROCE(5y)10.22%
ROICexgc growth 3Y-10.53%
ROICexgc growth 5Y-0.19%
ROICexc growth 3Y-9.99%
ROICexc growth 5Y-0.31%
OM growth 3Y-9.79%
OM growth 5Y-1.14%
PM growth 3Y-16.36%
PM growth 5Y-2.73%
GM growth 3Y-0.19%
GM growth 5Y-1.09%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 10.17
Debt/EBITDA 4.17
Cap/Depr 86.36%
Cap/Sales 3.1%
Interest Coverage 2.86
Cash Conversion 96.7%
Profit Quality 906.9%
Current Ratio 1.25
Quick Ratio 0.92
Altman-Z 2.05
F-Score5
WACC5.69%
ROIC/WACC0.65
Cap/Depr(3y)80.65%
Cap/Depr(5y)79.09%
Cap/Sales(3y)2.74%
Cap/Sales(5y)2.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.93%
EPS 3Y-1.33%
EPS 5Y4.44%
EPS Q2Q%-11.4%
EPS Next Y4.39%
EPS Next 2Y8.23%
EPS Next 3Y8.88%
EPS Next 5Y9.67%
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y3.76%
Revenue growth 5Y2.92%
Sales Q2Q%-4.54%
Revenue Next Year-3.24%
Revenue Next 2Y-1.87%
Revenue Next 3Y0.61%
Revenue Next 5Y4.06%
EBIT growth 1Y-49.8%
EBIT growth 3Y-6.39%
EBIT growth 5Y1.75%
EBIT Next Year30.22%
EBIT Next 3Y15.72%
EBIT Next 5Y9.68%
FCF growth 1Y-8.04%
FCF growth 3Y4.63%
FCF growth 5YN/A
OCF growth 1Y1.07%
OCF growth 3Y3.41%
OCF growth 5Y96.16%

AKZO NOBEL N.V. / AKZA.AS FAQ

What is the ChartMill fundamental rating of AKZO NOBEL N.V. (AKZA.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKZA.AS.


Can you provide the valuation status for AKZO NOBEL N.V.?

ChartMill assigns a valuation rating of 4 / 10 to AKZO NOBEL N.V. (AKZA.AS). This can be considered as Fairly Valued.


How profitable is AKZO NOBEL N.V. (AKZA.AS) stock?

AKZO NOBEL N.V. (AKZA.AS) has a profitability rating of 4 / 10.


How financially healthy is AKZO NOBEL N.V.?

The financial health rating of AKZO NOBEL N.V. (AKZA.AS) is 3 / 10.


What is the earnings growth outlook for AKZO NOBEL N.V.?

The Earnings per Share (EPS) of AKZO NOBEL N.V. (AKZA.AS) is expected to grow by 4.39% in the next year.